Boehringer Ingelheim has concluded phase one of their localization effort aimed at manufacturing their innovative thrombolytic medicines in Russia: the first batches of Metalyse (tenectaplase) for acute heart attack treatment were produced at NPO Petrovax Pharm facilities.

By the end of 2019, the companies intend to complete the transfer of technologies and to launch full-cycle production of innovative thrombolytic medicines at Petrovax Pharm’s production facility in the Moscow Region.

The chain is sold at the market price.

Vladimir Potanin, the owner and founder of Interros Group, one of the largest private investment companies in Russia, has completed acquisition of a controlling stake in Petrovax Pharm. For more details please visit www.petrovax.com

Widespread, consistent with the spirit and the demand of time national theatre chain Cinema Park, which played exceptional role in the formation of current film distribution market and has became the №1 theatre chain in Russia, started to operate 10 years ago with the opening of its first movie theatre Cinema Park at Kaluzhskaya metro station.